BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Valproic acid
,
rs2476601
,
GATA1
,
G-protein-coupled receptor binding
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TP 1
Summary
General Info
Curated Studies
Most Correlated Studies
Diffuse Large B-Cell Lymphoma Toledo cells treated with CARM1 inhibitor TP-064
Lung cancer A549 cells with shRNA-mediated AXL knockdown or treated with AXL inhibitor TP-0903
Treatment of WT or PDE10 KO mice with a selective PDE10 inhibitor
Whole body of C. elegans expressing odIs77-UbG76V-GFP transgenic cat-2, tbh-1, tdc-1, tph-1 mutants
Multiple myeloma cells treated with A2A and Beta-2 Adrenergic Receptor agonists with dexamethasone
Explore Curated Studies Results
Literature
Most Relevant Literature
Emerging View on the Molecular Functions of Sec62 and Sec63 in Protein Translocation.
Stepwise gating of the Sec61 protein-conducting channel by Sec63 and Sec62.
IFNT stimulates lysosomal function via type I IFN signaling pathway in pregnant bovine leukocytes.
Dose- and time-dependent effects of interferon tau on bovine endometrial gene expression.
Thirty years of interferon-tau research; Past, present and future perspective.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 1 Study of Oral TP-1454
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study
A Phase 1 Safety and PK Study of IV TP-271
A Phase 1 TP-271 Oral PK Single Ascending Dose Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ